Single-tablet regimens for HIV: Difference between revisions
From IDWiki
No edit summary |
(added genvoya) |
||
| Line 26: | Line 26: | ||
| elvitegravir/cobicistat (INI) |
| elvitegravir/cobicistat (INI) |
||
| Includes a P450 inhibitor to boost elvitegravir levels, with resultant drug-drug interactions. Avoid if CrCl <70. |
| Includes a P450 inhibitor to boost elvitegravir levels, with resultant drug-drug interactions. Avoid if CrCl <70. |
||
|- |
|||
| Genvoya |
|||
| tenofovir alafenamide / emtricitabine |
|||
| elvitegravir/cobicistat (INI) |
|||
| See Stribild, above. |
|||
|- |
|- |
||
| Biktarvy |
| Biktarvy |
||
| tenofovir alafenamide / emtricitabine |
|||
| FTC/TAF |
|||
| bictegravir (INI) |
|||
| BIC |
|||
| |
| |
||
|} |
|} |
||
Revision as of 01:39, 22 January 2020
See also HIV treatment
| Brand name | NRTIs | Non-NRTI | Notes |
|---|---|---|---|
| Triumeq | abacavir / lamivudine | dolutegravir (INI) | Highest barrier to resistance. Need to test for HLA-B5701 allele before starting. Avoid in hepatitis B coinfection. |
| Atripla | tenofovir disoproxil / emtricitabine | efavirenz | Older regimen. Neuropsychiatric symptoms, possibly including suicide. |
| Complera | tenofovir disoproxil / emtricitabine | rilpivirine | Avoid with viral loads (>100,000) or low CD4 (<200). Pill must be taken with food (>400kcal) and without PPIs. |
| Stribild | tenofovir disoproxil / emtricitabine | elvitegravir/cobicistat (INI) | Includes a P450 inhibitor to boost elvitegravir levels, with resultant drug-drug interactions. Avoid if CrCl <70. |
| Genvoya | tenofovir alafenamide / emtricitabine | elvitegravir/cobicistat (INI) | See Stribild, above. |
| Biktarvy | tenofovir alafenamide / emtricitabine | bictegravir (INI) |
